Prospera Financial Services Inc Ironwood Pharmaceuticals Inc Transaction History

Prospera Financial Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$10.1 - $11.6 $22,189 - $25,485	2,197 Added 9.2%	26,067 $277,000
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $9,581 - $11,605	924 Added 4.03%	23,870 $251,000
Q4 2022 Feb 08, 2023	BUY	$9.9 - $12.43 $12,097 - $15,189	1,222 Added 5.63%	22,946 $284,000
Q3 2022 Oct 27, 2022	BUY	$10.14 - $12.38 $21,588 - $26,357	2,129 Added 10.87%	21,724 $225,000
Q2 2022 Aug 08, 2022	SELL	$11.05 - $12.72 $20,906 - $24,066	-1,892 Reduced 8.81%	19,595 $226,000
Q1 2022 May 04, 2022	BUY	$10.61 - $12.88 $54,238 - $65,842	5,112 Added 31.22%	21,487 $270,000
Q4 2021 Feb 10, 2022	BUY	$10.86 - $13.95 $177,832 - $228,431	16,375 New	16,375 $191,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.